27th Aug 2015 07:01
PV Crystalox Solar PLC
Interim results to 30 June 2015
PV Crystalox Solar PLC (the "Group"), a long established supplier of photovoltaic ("PV") silicon wafers, today announces its interim results for the six months ended 30 June 2015.
Highlights
· Group continues to limit output to conserve cash
· Wafer shipments were104MW (H1 2014: 99MW)
· Request for ICC arbitration filed to resolve dispute with LT wafer contract customer
· Major polysilicon contract expires at end of 2015
Financial Overview
· Revenues €33.4m (H1 2014: €30.1m)
· Loss before taxes (EBT) €(9.5)m (H1 2014: €(6.9)m)
· Net cash €17.1m (31 December 2014: €24.6m)
· Inventories €28.0m (31 December 2014: €28.6m)
Iain Dorrity, Chief Executive Officer, commented:
"The adverse market conditions which have existed since 2011 are expected to continue in the short term and the recent devaluation of the Chinese currency is likely to intensify pressure on pricing. In view of the challenging environment and mindful of the need to protect shareholder value, the Board plans to complete a strategic review of the business before the end of the year."
Enquiries:
PV Crystalox Solar PLC +44 (0) 1235 437160
Iain Dorrity, Chief Executive Officer
Matthew Wethey, Chief Financial Officer and Group Secretary
About PV Crystalox Solar PLC
PV Crystalox Solar is a long established supplier to the global photovoltaic industry, producing multicrystalline silicon wafers for use in solar electricity generation systems.
Chairman and Chief Executive's joint statement
Overview and strategic update
The global photovoltaic industry environment has deteriorated further during 2015 with international trade disputes continuing and industry overcapacity, primarily in China, persisting. Pricing across the value chain has fallen sharply to historic lows during 2015 although wafer and cell prices have stabilised recently. Profitability remains elusive for wafer and cell manufacturing companies with market prices remaining below the cost of production despite the benefit of lower polysilicon pricing.
Chinese companies have increased their dominant position across the value chain according to figures released by CCID Think Tank, which is part of China's Ministry of Industry and Information Technology (MIIT). In 2014, China-based companies dominated global output and produced 43% of solar-grade polysilicon (132,000MT), 76% of solar-grade crystalline silicon wafers (38GW), 59% of crystalline silicon solar cells (33GW) and 70% of PV modules (35GW).
The Group shipped 104MW of wafers in H1 2015 which was similar to the volume shipped in the same period in the previous year (H1 2014: 99MW) and broadly in line with volume produced during the period. In view of the adverse market pricing the Group continues to limit output to conserve cash while maintaining a production volume consistent with its dual aims of developing a competitive cost position and a sustainable customer base in the shrinking accessible market which exists outside China.
In 2008 the Group secured several agreements to supply wafers to customers at fixed prices, which were very considerably above today's market levels, for periods of up to 7 years. No wafers have been supplied under these long term supply contracts since 2013 as the contracts have either expired, the customers entered insolvency or satisfactory termination agreements have been negotiated. One claim with the administrator of a customer in insolvency remains outstanding and a settlement is expected before the end of 2015.
The Group's remaining long term contract customer, which is one the world's leading PV companies, has failed to purchase wafers in line with its obligations. Despite extensive negotiations over the last two years it has not been possible to negotiate mutually agreeable terms which would enable the supply of wafers to be resumed. In view of the absence of any substantive progress a request for arbitration was filed in March 2015 with the International Court of Arbitration of the International Chamber of Commerce.
In common with most PV companies, the Group is burdened with long-term polysilicon purchase agreements which were signed in 2008 and 2010 in order to secure supply of this critical raw material necessary to meet obligations under wafer supply agreements. The contracted polysilicon pricing very considerably exceeds (by a factor of three) current market levels and is incompatible with current wafer prices. The Group has two such purchase contracts and has received good cooperation from both suppliers which has enabled agreement to be reached on adjustment of both pricing and volumes. In the case of the larger contract, the terms continue to be negotiated on a quarterly basis and the contract will expire at the end of 2015. The terms of the smaller contract were formally amended in 2014 and again more recently during this year to fix the pricing at a significantly lower level over the duration of the contract and to spread delivery of the outstanding volume over a longer period (until 2018).
As the Group's wafer production output has been reduced in view of the ongoing cash conservation policy which has been in operation since 2012, the contracted polysilicon purchase volumes are considerably in excess of requirements. Consequently it continues to be necessary to trade the surplus polysilicon at market prices in order to manage inventory and cash flow.
The Group's polysilicon trading activity has recovered significantly during 2015 following the lull in the H2 2014 which resulted in a build up in inventory at the end of 2014. Sales volumes in the year to date already exceed those achieved in the whole of 2014 and have enabled inventory to be stabilised.
Financial Review
In the first half of 2015 Group revenues of €33.4 million were 11% higher than during the same period in 2014 (€30.1 million) due to a 4% increase in wafer shipments, trading larger volumes of excess polysilicon than in H1 2014 and positive currency effects. Average spot market prices for wafers and polysilicon in H1 2015 have reduced in US dollar terms by around 25% compared to the same period in last year, but given the devaluation of the euro in 2015 compared to H1 2014 the average sales price reductions in euros are around 5% for the period.
The Group's loss before interest and taxes was €9.2million (H1 2014: €5.8 million). This increased loss was driven by a necessary adjustment to the onerous contract provision to reflect the reduction in spot price of polysilicon since the start of the year, a reduction in other income and increased other expenses which were partly offset by favourable currency movements.
Other income of €0.7 million was €2.6 million less than the €3.3m recognised in H1 2014 when the Group received a settlement from a long term contract customer and also released a provision related to supplier compensations. Other expenses were €0.4 million higher in the first six months of 2015 mainly due to fees in relation to arbitration proceedings with the Group's final long-term contract customer which has failed to purchase wafers in line with its contractual obligations. Offsetting these negative movements are currency gains of €2.1 million compared to losses of €1.7 million in H1 2014.
After including finance costs, which are mainly due to the unwinding of the discount rate used in the calculation of the Group's onerous contract provision, the Group's loss before taxes was €9.5 million (H1 2014: loss of €6.9 million).
The Group's net cash position at the end of the period was €17.1 million, which was €7.5 million lower than the net position of €24.6 million at the start of the year.
Risk Factors
The principal risks and uncertainties affecting the business activities of the Group were identified under the heading "Risk management and principal risks" in the Strategic Report on pages 10 to 11 of the 2014 Annual Report, a copy of which is available on the Group's website, www.pvcrystalox.com. In the view of the Board the key risks and uncertainties for the remaining six months of the financial year continue to be those set out in the 2014 Annual Report.
Market Drivers
Market analysts IHS are forecasting global solar installations to grow by as much as 30% in 2015 to reach 57 GW. China is expected to be the largest end-market for the third year running and to be the key driver of global demand. China had 33GW of capacity already installed at the end of 2014 and the National Energy Administration (NEA) is targeting a further 17.8GW to be installed in 2015. Three leading industry groups in China have recently urged the government to double the 2020 target for installed capacity to 200GW.
Japan and USA will continue to be the other major markets and are expected to install 10GW and 9GW respectively. The recently announced US Clean Power plan which targets 28% of electricity to be generated from renewable sources by 2030 should provide further stimulus to US PV installations in future years.
Long running trade disputes between China and both the USA and Europe continue to impact global markets.
Following an investigation into alleged unfair trade practices and dumping by Chinese solar firms the EU Commission (EC) introduced a minimum import price (MIP) for Chinese solar modules in December 2013. Under this trade agreement, an MIP of €0.56/W and an import quota of 7GW were imposed for two years until December 2015. However, following widespread allegations of circumvention of the MIP, European PV companies are expected to request formally that the EC carry out an expiration review which would necessitate the MIP being extended into 2016 while the review is carried out.
Earlier, in May 2015, following complaints that Chinese companies were shipping re-labelled solar modules from China to Europe via Malaysia and Taiwan, the EC had initiated an investigation into solar imports of products exported by Chinese suppliers, from those countries.
In July 2015 the US Department of Commerce announced the outcome of its review of anti-dumping (AD) and anti-subsidy (AS) rates on imported Chinese modules. The revision of the duties which were originally imposed in December 2012 delivered mixed results for Chinese suppliers. In most case AD duties were decreased but the impact was largely offset by an increase in AS rates so that the net duties for most major companies were around 30%. The review also covers products from Taiwan in an effort to prevent Chinese companies from circumventing duties. Previously duties were only imposed on cells, so Chinese firms were able to avoid the 2012 duties by importing modules with Taiwanese cells.
Outlook
The adverse market conditions which have existed since 2011 are expected to continue in the short term and the recent devaluation of the Chinese currency is likely to intensify pressure on pricing. In view of the challenging environment and mindful of the need to protect shareholder value, the Board plans to complete a strategic review of the business before the end of the year. The review will take account of the Group's cash position and production cost structure, industry overcapacity and the prospects for rational pricing returning to the market.
John Sleeman
Chairman
Dr Iain Dorrity
Chief Executive Officer
26 August 2015
Consolidated statement of comprehensive income
for the six months ended 30 June 2015
Notes | Six months ended 30 June 2015 €'000 | Six months ended 30 June 2014 €'000 | Year ended 31 December 2014 €'000 | |
Revenues | 4 | 33,421 | 30,087 | 53,333 |
Cost of materials and services | 9 | (38,925) | (31,337) | (65,694) |
Personnel expenses | (3,982) | (4,046) | (6,620) | |
Depreciation and impairment of property, plant and equipment and amortisation of intangible assets | (164) | (157) | (337) | |
Other income | 652 | 3,274 | 12,132 | |
Other expenses | (2,317) | (1,924) | (4,163) | |
Currency gains/(losses) | 2,135 | (1,671) | 9,043 | |
Loss before interest and taxes ("EBIT") | (9,180) | (5,774) | (2,306) | |
Finance income | 25 | 27 | 106 | |
Finance cost | (352) | (1,187) | (2,450) | |
Loss before taxes ("EBT") | (9,507) | (6,934) | (4,650) | |
Income taxes | 6 | 3 | (3) | (2) |
Loss attributable to owners of the parent | (9,504) | (6,937) | (4,652) | |
Other comprehensive income |
|
| ||
Currency translation adjustment | 4,257 | 1,960 | 2,498 | |
Total comprehensive loss |
|
| ||
Attributable to owners of the parent | (5,247) | (4,977) | (2,154) | |
Basic and diluted loss per share in Euro cents |
|
|
| |
From loss for the period/year | 7 | (6.1) | (4.4) | (3.0) |
The accompanying notes form an integral part of these financial statements.
Consolidated balance sheet
as at 30 June 2015
| Notes | As at 30 June 2015 €'000 | As at 30 June 2014 €'000 | As at 31 December 2014 €'000 |
Intangible assets | 34 | 47 | 38 | |
Property, plant and equipment | 8 | 2,354 | 2,385 | 2,355 |
Pension surplus | - | 108 | - | |
Other long-term assets | 5,730 | 11,246 | 5,425 | |
Total non-current assets |
| 8,118 | 13,786 | 7,818 |
Cash and cash equivalents | 17,051 | 35,396 | 24,592 | |
Trade accounts receivable | 4,238 | 7,663 | 5,341 | |
Inventories |
| 27,962 | 16,966 | 28,630 |
Prepaid expenses and other assets | 6,762 | 10,473 | 12,380 | |
Current tax assets |
| 8 | 12 | 16 |
Total current assets |
| 56,021 | 70,510 | 70,959 |
Total assets |
| 64,139 | 84,296 | 78,777 |
Loans payable | - | - | - | |
Trade accounts payable | 1,373 | 1,099 | 1,762 | |
Deferred revenue | 3,254 | 3,316 | 3,235 | |
Accrued expenses | 1,208 | 2,226 | 1,564 | |
Provisions | 9 | 5,542 | 14,699 | 14,577 |
Deferred grants and subsidies | 90 | 135 | 111 | |
Current tax liabilities | - | 199 | 156 | |
Other current liabilities |
| 92 | 44 | 72 |
Total current liabilities |
| 11,559 | 21,718 | 21,477 |
Accrued expenses | 123 | 109 | 111 | |
Provisions | 9 | 1,929 | 8,732 | 1,019 |
Other non-current liabilities |
| 205 | 43 | 236 |
Total non-current liabilities |
| 2,257 | 8,884 | 1,366 |
Share capital | 12,332 | 12,332 | 12,332 | |
Share premium | 50,511 | 50,511 | 50,511 | |
Other reserves | 25,096 | 25,096 | 25,096 | |
Shares held by the EBT | 5 | (679) | (7,211) | (679) |
Share-based payment reserve | 377 | 810 | 741 | |
Reverse acquisition reserve | (3,601) | (3,601) | (3,601) | |
Accumulated losses | (17,135) | (2,870) | (7,631) | |
Currency translation reserve |
| (16,578) | (21,373) | (20,835) |
Total equity |
| 50,323 | 53,694 | 55,934 |
Total liabilities and equity | 64,139 | 84,296 | 78,777 |
The accompanying notes form an integral part of these financial statements.
Consolidated statement of changes in equity
for the six months ended 30 June 2015
| Share capital €'000 | Share premium €'000 | Other reserves €'000 | Shares held by the EBT €'000 | Share- based payment reserve €'000 | Reverse acquisition reserve €'000 | Retained earnings/ (accumulated losses) €'000 | Currency translation reserve €'000 | Total equity €'000 |
As at 1 January 2015 | 12,332 | 50,511 | 25,096 | (679) | 741 | (3,601) | (7,631) | (20,835) | 55,934 |
Share-based payment charge | - | - | - | - | 191 | - | - | - | 191 |
Award of shares | - | - | - | - | (555) | - | - | - | (555) |
Transactions with owners | - | - | - | - | (364) | - | - | - | (364) |
Loss for the period | - | - | - | - | - | - | (9,504) | - | (9,504) |
Currency translation adjustment | - | - | - | - | - | - | - | 4,257 | 4,257 |
Total comprehensive loss | - | - | - | - | - | - | (9,504) | 4,257 | (5,247) |
As at 30 June 2015 | 12,332 | 50,511 | 25,096 | (679) | 377 | (3,601) | (17,135) | (16,578) | 50,323 |
As at 1 January 2014 | 12,332 | 50,511 | 25,096 | (7,610) | 922 | (3,601) | 4,067 | (23,333) | 58,384 |
Share-based payment charge | - | - | - | - | 56 | - | - | - | 56 |
Award of shares | - | - | - | 399 | (168) | - | - | - | 231 |
Transactions with owners | - | - | - | 399 | (112) | - | - | - | 287 |
Loss for the period | - | - | - | - | - | - | (6,937) | - | (6,937) |
Currency translation adjustment | - | - | - | - | - | - | - | 1,960 | 1,960 |
Total comprehensive loss | - | - | - | - | - | - | (6,937) | 1,960 | (4,977) |
As at 30 June 2014 | 12,332 | 50,511 | 25,096 | (7,211) | 810 | (3,601) | (2,870) | (21,373) | 53,694 |
Consolidated cash flow statement
for the six months ended 30 June 2015
| Notes | Six months ended 30 June 2015 €'000 | Six months ended 30 June 2014 €'000 | Year ended 31 December 2014 €'000 |
Loss before taxes | (9,507) | (6,934) | (4,650) | |
Adjustments for: |
| |||
Net interest expense | 327 | 1,160 | 2,344 | |
Depreciation and amortisation | 164 | 157 | 337 | |
Change in pension accruals and share based payment charge | (353) | 287 | - | |
Decrease in provisions | (9,847) | (5,345) | (14,761) | |
Gain from the disposal of property, plant and equipment | - | (2) | (2) | |
Losses in foreign currency exchange | - | - | 156 | |
Change in deferred grants and subsidies | (21) | (24) | (48) | |
(19,237) | (10,701) | (16,624) | ||
Changes in working capital |
| |||
Decrease/(increase) in inventories | 3,298 | (3,370) | (14,847) | |
Decrease in accounts receivables | 2,918 | 6,749 | 9,074 | |
Decrease in accounts payables and deferred revenue | (2,380) | (2,804) | (2,926) | |
Decrease in other assets | 6,965 | 5,342 | 9,576 | |
Decrease/(increase) in other liabilities | 18 | (9) | 22 | |
(8,418) | (4,793) | (15,725) | ||
Income taxes (paid)/received | (145) | 53 | 7 | |
Interest received | 25 | 27 | 44 | |
Net cash flows used in operating activities | (8,538) | (4,713) | (15,674) | |
Cash flow from investing activities |
| |||
Proceeds from sale of property, plant and equipment | - | 2 | 2 | |
Proceeds from investment grants and subsidies | - | 7 | 7 | |
Payments to acquire property, plant and equipment and intangibles |
| (11) | (136) | (251) |
Net cash flows used in investing activities | (11) | (127) | (242) | |
Cash flow from financing activities |
| |||
Repayment of bank and other borrowings | - | (712) | (712) | |
Interest paid | - | (1) | (1) | |
Net cash flows used in financing activities | - | (713) | (713) | |
Cash generated from operations |
| (8,549) | (5,553) | (16,629) |
Effects of foreign exchange rate changes on cash and cash equivalents |
| 1,008 | 1,049 | 1,321 |
Cash and equivalents at beginning of the period | 24,592 | 39,900 | 39,900 | |
Cash and equivalents at end of the period | 17,051 | 35,396 | 24,592 |
The accompanying notes form an integral part of these financial statements.
Notes to the consolidated interim financial statements
for the six months ended 30 June 2015
1. Basis of preparation
These condensed consolidated interim financial statements are for the six months ended 30 June 2015. They have been prepared in accordance with International Accounting Standard ("IAS") 34, 'Interim Financial Reporting'. They do not include all the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2014.
The statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the financial statements for the year ended 31 December 2014.
The nature of the Group's operation means that it can vary production levels to match market requirements. As part of the cash conservation measures and the associated planning assumptions, production output currently remains reduced to match expected demand. In line with the Group's strategy of retaining flexibility in production levels, production can be brought back on stream when market conditions allow.
On 30 June 2015 there was a net cash balance of €17.1 million, including funds held by an employee benefit trust.
As part of its normal business practice, the Group regularly prepares both annual and longer-term plans which are based on the directors' expectations concerning key assumptions. The assumptions around contracted sales volumes and prices and contracted purchase volumes and prices are based on management's expectations. As a result of these modelling assumptions the base plans indicate that the Group will be able to operate within its net cash reserves for the foreseeable future.
Therefore, whilst any consideration of future matters involves making a judgement at a particular point in time about future events that are inherently uncertain, the directors, after careful consideration and after making appropriate enquiries, are of the opinion that the Group has adequate resources to continue in operational existence for at least twelve months from the date of approval of the financial statements. Thus the Group continues to adopt the going concern basis of accounting in preparing the interim financial statements.
Were the Group not to adopt the going concern basis at any point, all assets and liabilities would be reclassified as short term and valued on a break-up basis.
2. Basis of consolidation
The Group financial statements consolidate those of the parent company and its subsidiary undertakings drawn up to 30 June 2015. Subsidiaries are entities over which the Group has the power to control the financial and operating policies so as to obtain benefits from its activities. The Group obtains and exercises control through voting rights. Consolidation is conducted by eliminating the investment in the subsidiary with the parent's share of the net equity of the subsidiary.
The results of any subsidiary sold or acquired are included in the Consolidated Statement of Comprehensive Income up to, or from, the date control passes.
3. Functional and presentational currency
Items included in the financial statements of each of the Group's entities are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). The functional currency of the parent company is Sterling. The financial information has been presented in Euros, which is the Group's presentational currency. The Euro has been selected as the Group's presentational currency as this is the currency used in its significant contracts. The financial statements are presented in round thousands..
4. Segment reporting
The chief operating decision-maker, who is responsible for allocating resources and assessing performance, has been identified as the executive Board. The Group is organised around the production and supply of one product, multicrystalline silicon wafers. Accordingly, the Board reviews the performance of the Group as a whole and there is only one operating segment. Disclosure of reportable segments under IFRS 8 is therefore not made.
Geographical information for the six months ended 30 June 2015
| Japan €'000 | Taiwan €'000 | Canada €'000 | Germany €'000 | United Kingdom €'000 | Rest of Europe €'000 | Rest of World €'000 | Group €'000 |
Revenues | ||||||||
By entity's country of domicile | 185 | - | - | 2,035 | 31,201 | - | - | 33,421 |
By country from which derived | 185 | 17,146 | 9,760 | 39 | - | 5,423 | 868 | 33,421 |
Non-current assets* | ||||||||
By entity's country of domicile | 231 | - | - | 867 | 7,019 | - | - | 8,117 |
* Excludes financial instruments, deferred tax assets and post-employment benefit assets.
Two customers accounted for more than 10% of Group revenue each and sales to these customers are as follows (figures in €'000):
1. 14,388 (Taiwan);
2. 9,760 (Canada).
No sales to Korea were made in the period.
Geographical information for the six months ended 30 June 2014
| Japan €'000 | Taiwan €'000 | Korea €'000 | Germany €'000 | United Kingdom €'000 | Rest of Europe €'000 | Rest of World €'000 | Group €'000 |
Revenues |
|
|
|
|
|
|
|
|
By entity's country of domicile | 124 | - | - | 2,139 | 27,824 | - | - | 30,087 |
By country from which derived | 149 | 18,881 | 4,299 | 62 | - | 6,108 | 588 | 30,087 |
Non-current assets* |
|
|
|
|
|
|
|
|
By entity's country of domicile | 218 | - | - | 1,064 | 12,396 | - | - | 13,678 |
* Excludes financial instruments, deferred tax assets and post-employment benefit assets.
Four customers accounted for more than 10% of Group revenue each and sales to these customers are as follows (figures in €'000):
1. 8,590 (Taiwan);
2. 5,421 (Taiwan);
3. 4,244 (Korea); and
4. 3,820 (Taiwan).
Sales to Canada of €352k are included in Rest of World.
5. Employee Benefit Trust
As at 30 June 2015 the Employee Benefit Trust ("EBT") held 3,853,910 shares (2.4%) of the issued share capital in the Company. It holds these shares in trust for the benefit of employees.
In December 2014 the Directors agreed to write down the value of the shares held by the EBT to the market value at 31 December 2014. The share price was 13 pence per ordinary share of 5.2 pence each. This adjustment alters the value of the shares held by the EBT and reduces retained earnings by €6.868 million
6. Income tax
The average taxation rate shown in the Consolidated Statement of Comprehensive Income is nil% (H1 2014: nil%).
The anticipated long-term average tax rate for the Group, normalised on the basis that the Group returns to profitability, is approximately 20%.
7. Earnings per share
Net earnings per share is computed by dividing the net (loss)/profit for the period attributable to ordinary shareholders of €9.5 million (H1 2014: loss of €6.9 million) by the weighted average number of ordinary shares outstanding during the year.
Diluted net earnings per share is computed by dividing the (loss)/profit for the year by the weighted average number of ordinary shares outstanding and, when dilutive, adjusted for the effect of all potentially dilutive shares, including share options. A s the Group is currently loss making, the diluted loss per share is equal to the basic loss per share.
The calculation of the weighted average number of ordinary shares is set out below:
| Six months ended 30 June 2015 | Six months ended 30 June 2014 |
Number of shares | 160,278,975 | 160,725,335 |
Average number of shares held by the EBT in the period | (3,853,910) | (3,990,051) |
Weighted average number of shares for basic earnings per share calculation | 156,425,065 | 156,735,284 |
Shares granted but not vested | 4,017,108 | 2,127,348 |
Weighted average number of shares for fully diluted earnings per share calculation | 160,442,173 | 158,862,632 |
8. Property, plant and equipment
Additions to property, plant and equipment in the six months ended 30 June 2015 were less than €0.1 million (H1 2014: less than €0.1 million).
9. Onerous contract provision
Included in provisions is an onerous contract provision of €7.4 million. The onerous contract provision is an allowance for the loss arising on the difference between raw material costs under these contracts and the anticipated selling price of the Group's end product. Following a review of all the latest market information and a review of the inputs to the onerous contract provision, the following movements are reflected in the financial statements.
| As at 30 June 2015 €'000 | As at 30 June 2014 €'000 | As at 31 December 2014 €'000 |
Onerous contract provision brought forward | 15,542 | 26,526 | 26,526 |
Exchange differences | (1,920) | 1,373 | (8,902) |
Unwinding of discounting factor | 332 | 1,185 | 2,390 |
Utilised | (11,712) | (6,412) | (12,634) |
Additional provision/(release) charged/(credited) to the income statement | 5,185 | 726 | 8,162 |
Onerous contract provision carried forward | 7,427 | 23,398 | 15,542 |
10. Changes in contingent assets and liabilities
There were no changes in contingent assets and liabilities.
11. Related party disclosures
The Group defines related parties as the senior executives of the Group and also companies that these persons could have a material influence on as related parties as well as other Group companies. During the reporting period, none of the shareholders had control over or a material influence in the parent company.
Transactions between the Company and its subsidiaries have been eliminated on.
12. Post balance sheet events
There are no significant post balance sheet events.
13. Approval of interim financial statements
The unaudited consolidated interim financial statements for the six months ended 30 June 2015 were approved by the Board of Directors on 26 August 2015.
The financial information for the year ended 31 December 2014 set out in this Interim Report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2014 have been filed with the Registrar of Companies. The Auditors' Report on those financial statements was unqualified and did not contain statements under Section 498(2) or Section 498(3) of the Companies Act 2006.
Statement of directors' responsibilities
to the members of PV Crystalox Solar PLC
The directors confirm that this condensed set of financial statements has been prepared in accordance with IAS 34, 'Interim Financial Reporting' as adopted by the European Union and that this Interim Report includes a fair review of the information required by the Disclosure and Transparency Rules of the Financial Services Authority, paragraphs DTR 4.2.7 and DTR 4.2.8.
The directors of PV Crystalox Solar PLC are listed at the end of this Interim Report and their biographies are included in the PV Crystalox Solar Annual Report for the year ended 31 December 2014.
By order of the Board
Matthew Wethey
Chief Financial Officer and Group Secretary
26 August 2015
Related Shares:
PVCS.L